Dexcom Inc Stock Price Prediction
| DXCM Stock | USD 89.91 0.84 0.93% |
Momentum 54
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.39) | EPS Estimate Next Quarter 0.3769 | EPS Estimate Current Year 2.0171 | EPS Estimate Next Year 2.4693 | Wall Street Target Price 101.44 |
Using DexCom hype-based prediction, you can estimate the value of DexCom Inc from the perspective of DexCom response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards DexCom using DexCom's stock options and short interest. It helps to benchmark the overall future attitude of investors towards DexCom using crowd psychology based on the activity and movement of DexCom's stock price.
DexCom Short Interest
An investor who is long DexCom may also wish to track short interest. As short interest increases, investors should be becoming more worried about DexCom and may potentially protect profits, hedge DexCom with its derivative instruments, or be ready for some potential downside.
200 Day MA 87.3488 | Short Percent 0.0285 | Short Ratio 2.81 | Shares Short Prior Month 8.8 M | 50 Day MA 83.4008 |
DexCom Inc Hype to Price Pattern
Investor biases related to DexCom's public news can be used to forecast risks associated with an investment in DexCom. The trend in average sentiment can be used to explain how an investor holding DexCom can time the market purely based on public headlines and social activities around DexCom Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of DexCom's market sentiment to its price can help taders to make decisions based on the overall investors consensus about DexCom.
DexCom Implied Volatility | 0.42 |
DexCom's implied volatility exposes the market's sentiment of DexCom Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if DexCom's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that DexCom stock will not fluctuate a lot when DexCom's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in DexCom to buy its stock at a price that has no basis in reality. In that case, they are not buying DexCom because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
DexCom after-hype prediction price | USD 90.55 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current DexCom contract
Based on the Rule 16, the options market is currently suggesting that DexCom Inc will have an average daily up or down price movement of about 0.0263% per day over the life of the 2025-04-17 option contract. With DexCom trading at USD 89.91, that is roughly USD 0.0236 . If you think that the market is fully incorporating DexCom's daily price movement you should consider acquiring DexCom Inc options at the current volatility level of 0.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
DexCom |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
DexCom After-Hype Price Prediction Density Analysis
As far as predicting the price of DexCom at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in DexCom or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of DexCom, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
DexCom Estimiated After-Hype Price Volatility
In the context of predicting DexCom's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on DexCom's historical news coverage. DexCom's after-hype downside and upside margins for the prediction period are 88.57 and 92.53, respectively. We have considered DexCom's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
DexCom is very steady at this time. Analysis and calculation of next after-hype price of DexCom Inc is based on 3 months time horizon.
DexCom Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as DexCom is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DexCom backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with DexCom, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.26 | 1.97 | 0.79 | 0.38 | 6 Events / Month | 9 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
89.91 | 90.55 | 0.95 |
|
DexCom Hype Timeline
DexCom Inc is currently traded for 89.91. The entity has historical hype elasticity of 0.79, and average elasticity to hype of competition of 0.38. DexCom is forecasted to increase in value after the next headline, with the price projected to jump to 90.55 or above. The average volatility of media hype impact on the company the price is about 64.8%. The price boost on the next news is projected to be 0.95%, whereas the daily expected return is currently at 0.26%. The volatility of related hype on DexCom is about 135.79%, with the expected price after the next announcement by competition of 90.29. The company reported the previous year's revenue of 4.03 B. Net Income was 576.2 M with profit before overhead, payroll, taxes, and interest of 2.44 B. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out DexCom Basic Forecasting Models to cross-verify your projections.DexCom Related Hype Analysis
Having access to credible news sources related to DexCom's direct competition is more important than ever and may enhance your ability to predict DexCom's future price movements. Getting to know how DexCom's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how DexCom may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TNDM | Tandem Diabetes Care | (0.49) | 10 per month | 2.53 | 0.1 | 6.14 | (4.81) | 14.52 | |
| INSP | Inspire Medical Systems | 13.50 | 8 per month | 3.11 | 0.04 | 5.02 | (5.11) | 18.97 | |
| SWAV | Shockwave Medical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PEN | Penumbra | 4.64 | 8 per month | 1.34 | 0.11 | 3.51 | (2.66) | 15.80 | |
| PODD | Insulet | (1.12) | 8 per month | 1.42 | 0.02 | 3.21 | (1.72) | 6.27 | |
| IART | Integra LifeSciences Holdings | (0.24) | 10 per month | 2.64 | 0.06 | 3.70 | (3.78) | 10.46 | |
| SENS | Senseonics Holdings | 0.03 | 7 per month | 4.99 | 0.19 | 19.44 | (9.62) | 93.32 | |
| EW | Edwards Lifesciences Corp | (0.19) | 7 per month | 1.17 | 0.06 | 3.51 | (1.95) | 8.87 | |
| INMD | InMode | 0.30 | 7 per month | 2.46 | 0.04 | 2.92 | (3.14) | 11.90 | |
| MDT | Medtronic PLC | 1.00 | 6 per month | 1.62 | 0.04 | 2.27 | (1.65) | 11.49 | |
| ABT | Abbott Laboratories | 0.42 | 8 per month | 0.84 | 0.18 | 2.53 | (1.65) | 7.53 | |
| BSX | Boston Scientific Corp | 1.66 | 6 per month | 0.55 | 0.24 | 1.67 | (1.12) | 6.63 | |
| ZBH | Zimmer Biomet Holdings | (0.65) | 11 per month | 0.00 | (0.08) | 1.67 | (1.71) | 8.09 |
DexCom Additional Predictive Modules
Most predictive techniques to examine DexCom price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for DexCom using various technical indicators. When you analyze DexCom charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About DexCom Predictive Indicators
The successful prediction of DexCom stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as DexCom Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of DexCom based on analysis of DexCom hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to DexCom's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to DexCom's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 4.32 | 4.82 | 0.99 | 0.94 | Days Of Inventory On Hand | 109.03 | 153.18 | 126.36 | 68.46 |
Story Coverage note for DexCom
The number of cover stories for DexCom depends on current market conditions and DexCom's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that DexCom is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about DexCom's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
DexCom Short Properties
DexCom's future price predictability will typically decrease when DexCom's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of DexCom Inc often depends not only on the future outlook of the potential DexCom's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. DexCom's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 412.7 M | |
| Cash And Short Term Investments | 2.6 B |
Check out DexCom Basic Forecasting Models to cross-verify your projections. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.39) | Earnings Share 1.42 | Revenue Per Share | Quarterly Revenue Growth 0.076 | Return On Assets |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.